Cambridge Cognition Holdings

1. 06 Oct 26
   COG joins Imperial College-led NHS Study

   Cambridge Cognition joins Imperial College-led NHS study bringing earlier

   RNS 9807702 ↗
2. 23 Sep 26
   Director/PDMR Share Purchases Director buys

   Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology company, was informed on 18 September 2026 that, on the same day, Nick Rodgers, Non-Executive Chair of the Company, purchased 19,000 ordinary shares of 0.01 pence each ("Ordinary...

   RNS 9787786 ↗
3. 21 Sep 26
   Partnership with C2N and The Alzheimer's Trust

   C2N Diagnostics Expands Global Partnerships in United Kingdom on

   RNS 9780838 ↗
4. 16 Sep 26
   Half-year Results

   Interim Results for the six months to 30 June 2026

   RNS 9773942 ↗
5. 27 Jul 26
   Trading Update

   Cambridge, UK, 27 July 2026: Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, announces a trading update...

   RNS 9688441 ↗
6. 10 Jul 26
   Result of GM, TVR & Director/PDMR Dealing Director buys

   Results of General Meeting, Total Voting Rights and Director/PDMR Dealing

   RNS 9663589 ↗
7. 30 Jun 26
   Result of Retail Offer

   Cambridge Cognition (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, announces that the Retail Offer launched on 24 June 2026 has now...

   RNS 9642993 ↗
8. 24 Jun 26
   Retail Offer

   Cambridge Cognition (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, is pleased to announce a retail offer via BookBuild (the "Retail...

   RNS 9633302 ↗
9. 24 Jun 26
   Result of Placing & Posting of Circular

   Cambridge Cognition (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, is pleased to announce that, further to the announcement made on 23...

   RNS 9633029 ↗
10. 23 Jun 26
    Proposed Equity Fundraising and Retail Offer

    THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY.

    RNS 9632792 ↗
11. 01 Jun 26
    COG to present at Mello 2026

    Cambridge, UK, 1 June 2026: Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, announces that the Company...

    RNS 9593435 ↗
12. 28 May 26
    Launch of brain health study with Oura

    Cambridge Cognition and Oura launch large-scale brain health study integrating cognition with wearable sleep and physiological data

    RNS 9590404 ↗
13. 13 Apr 26
    Results for the year ended 31 December 2025

    Results for the year ended 31 December 2025

    RNS 9515707 ↗
14. 07 Apr 26
    Appointment of Nominated Adviser and Joint Broker

    Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, announces the appointment of Cavendish Capital Markets...

    RNS 9507166 ↗
15. 11 Mar 26
    Monument Therapeutics MT1988 First Patient Dosed

    Cambridge Cognition Investment, Monument Therapeutics, Announces First Patient Dosed in Clinical Trial of MT1988 in Patients at Clinical High Risk for Psychosis

    RNS 9468251 ↗
16. 16 Feb 26
    Commercialisation Agreement

    to scale early cognitive screening with CANTAB Pathway™ in India

    RNS 9431340 ↗
17. 09 Feb 26
    Change of Joint Broker

    Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, announces the appointment of Singer Capital Markets as...

    RNS 9420123 ↗
18. 19 Jan 26
    Trading Update

    Trading update for the year ended 31 December 2025

    RNS 9363941 ↗
19. 05 Nov 25
    Change of Auditor

    Cambridge Cognition Holdings plc (AIM:COG), the brain health software group specialising in digital health products that advance brain health research and treatment, announces the appointment of Cooper Parry Group Limited ("Cooper Parry") as the Company's...

    RNS 9212967 ↗
20. 05 Nov 25
    Board Updates

    Cambridge Cognition Holdings plc (AIM: COG), the brain health software group specialising in digital health products that advance brain health research and treatment, announces the following changes to the board of directors.

    RNS 9212827 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.